Drugs News and Research

RSS

State highlights: Calif. readies new checks on foster kid psych meds; Kan. employment support for those with mental illness

In a significant step toward curbing the overuse of psychiatric drugs in California's foster care system, doctors will soon be required to get extra authorization to prescribe antipsychotics, a new safeguard to protect some of the state's most overmedicated children. Beginning Oct. 1, a state pharmacist must verify the "medical necessity" of each antipsychotic prescription before the medications can be given to children who are 17 and younger and covered by Medi-Cal, the state's health program for the poor that also includes foster children (De Sa, 9/18).

22 Sep 2014

New research identifies novel cellular factors vital for CCHFV infection

New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne virus which causes a severe hemorrhagic disease in humans similar to that caused by Ebolavirus, has identified new cellular factors essential for CCHFV infection.

22 Sep 2014

Sequencing the Asian liver fluke genome: an interview with Dr Neil Young

Opisthorchis viverrini is a parasitic flatworm (or liver fluke) endemic throughout Thailand, the Lao People’s Democratic Republic, Vietnam and Cambodia. Humans are infected with this parasite when they eat a fluke encysted in inadequately cooked/preserved freshwater fish.

21 Sep 2014

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

Researchers at Jacksonville's campus of Mayo Clinic have discovered a defect in a key cell-signaling pathway they say contributes to both overproduction of toxic protein in the brains of Alzheimer's disease patients as well as loss of communication between neurons - both significant contributors to this type of dementia.

21 Sep 2014

SLU pediatric researcher to study efficacy of new hepatitis C drug treatment in children

After the success of a new drug treatment in adults with hepatitis C infection, a Saint Louis University pediatric researcher is testing the safety and efficacy of the medications in children.

21 Sep 2014

Demand for $84,000 hepatitis C drug slows

Health care providers may be waiting for other, soon-to-be-released drugs to treat hepatitis C. Also, an Indian pharmaceutical company faces Justice Department questions on pricing data for Medicaid.

19 Sep 2014

Obama orders plan to reduce peril of antibiotic resistance

The measures include incentives to develop new drugs, tighter control of existing ones and better tracking of resistant microbes.

19 Sep 2014

CDC urges all adults to get flu vaccination

Influenza vaccination coverage estimates show an encouraging upward trend overall, but coverage among healthy 18 to 64 year-olds has yet to top 40 percent, according to new data announced at a news conference held today by the National Foundation for Infectious Diseases.

19 Sep 2014

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

For starters, my strong hunch from my own reporting in the region over the past couple years - including several trips to Kentucky for a new book on McConnell - is that the Democrats' biggest problem in Appalachia and the Upland South is not that the people who are benefitting from Obamacare or would stand to benefit from it if their states fully implemented the law are voting against their own interests, for Republicans.

19 Sep 2014

Longer looks: Lithium in the water; controlling cancer; recovering from brain injury

There are many kinds of cancer, but treatments have typically combatted them in one way only: by attempting to destroy the cancerous cells. Surgery aims to remove the entire growth from the body; chemotherapy drugs are toxic to the cancer cells; radiation generates toxic molecules that break up the cancer cells' DNA and proteins, causing their demise.

19 Sep 2014

Exercise may have added benefit for cancer patients undergoing chemotherapy: Study

Study after study has proven it true: exercise is good for you. But new research from University of Pennsylvania scientists suggests that exercise may have an added benefit for cancer patients undergoing chemotherapy.

19 Sep 2014

Penn Medicine, Wistar Institute awarded NCI grants for four new melanoma research projects

Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million SPORE grant from the National Cancer Institute. The five-year Specialized Programs of Research Excellence, or SPORE, grant will fund four new melanoma research projects that aim to translate fundamental laboratory discoveries into new therapeutics to treat melanoma and other skin cancers.

18 Sep 2014

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.

18 Sep 2014

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

Scientists at The Scripps Research Institute have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria.

18 Sep 2014

Sanofi, MyoKardia partner to develop targeted therapeutics for cardiomyopathies

Sanofi and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic heart disease, announced today a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most common forms of heart muscle disease.

18 Sep 2014

Drugs News and Research

State highlights: Calif. readies new checks on foster kid psych meds; Kan. employment support for those with mental illness

New research identifies novel cellular factors vital for CCHFV infection

Sequencing the Asian liver fluke genome: an interview with Dr Neil Young

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

SLU pediatric researcher to study efficacy of new hepatitis C drug treatment in children

Demand for $84,000 hepatitis C drug slows

Obama orders plan to reduce peril of antibiotic resistance

CDC urges all adults to get flu vaccination

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

Longer looks: Lithium in the water; controlling cancer; recovering from brain injury

Exercise may have added benefit for cancer patients undergoing chemotherapy: Study

Penn Medicine, Wistar Institute awarded NCI grants for four new melanoma research projects

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

Sanofi, MyoKardia partner to develop targeted therapeutics for cardiomyopathies

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Disrupting cancer regulator MYC: an interview with Professor Kim Janda

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

S. pneumoniae drug susceptibility tracked in Japan

‘Reassuring’ findings on microvascular risk in diabetic statin users

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News